Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - A cluster randomised controlled trial (FIAT)

BMC Psychiatry

Volumn 9, Issue , 2009, Pages 61-

  Priebe, Stefan ^a   Burton, Alexandra ^a   Ashby, Deborah ^b   Ashcroft, Richard ^c   Burns, Tom ^d   David, Anthony ^e   Eldridge, Sandra ^a   Firn, Mike ^f   Knapp, Martin ^g   McCabe, Rose ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f SPRINGFIELD UNIVERSITY HOSPITAL   (United Kingdom)

^g LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FINANCIAL MANAGEMENT; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MENTAL HEALTH SERVICE; MENTAL PATIENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PSYCHOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUICIDE ATTEMPT; TREATMENT OUTCOME; VIOLENCE; WORKING TIME;

EID: 70449366842     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-9-61     Document Type: Article

References (26)

1. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. Scientific review. JAMA 2002, 288(22):2868-2879. 10.1001/jama.288.22.2868, 12472329.
2. Nose M, Barbui C, Gray R, Tansella M. Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry 2003, 183:197-206. 10.1192/bjp.183.3.197, 12948991.
3. Giuffrida A, Togerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ 1997, 315:703-707. 2127496, 9314754.
4. Carey KB, Carey MP. Enhancing the treatment attendance of mentally ill chemical abusers. Journal of Behaviour Therapy and Experimental Psychiatry 1990, 21:205-209.
5. Helmus TC, Schoener RP, Saules KK, Roll JM. Reinforcement of counselling attendance and alcohol abstinence in a community-based dual-diagnosis treatment program: a feasibility study. Psychol Addict Behav 2003, 17:249-251. 10.1037/0893-164X.17.3.249, 14498820.
6. Messina N, Farabee D, Rawson R. Treatment Responsivity of Cocaine-Dependent Patients With Antisocial Personality Disorder to Cognitive-Behavioral and Contingency Management Interventions. J Consult Clin Psychol 2003, 71:320-329. 10.1037/0022-006X.71.2.320, 12699026.
7. Post EP, Cruz M, Harman J. Incentive Payments for Attendance at Appointments for Depression Among Low-Income African Americans. Psychiatr Serv 2006, 57:414-416. 10.1176/appi.ps.57.3.414, 16525004.
8. Roll JM, Higgins ST, Steingard S, McGinley M. Use of Monetary Reinforcement to Reduce the Cigarette Smoking of Persons With Schizophrenia: Feasibility Study. Exp Clin Psychopharmacol 1998, 6:157-161. 10.1037/1064-1297.6.2.157, 9608347.
9. Roll LM, Chermack ST, Chudzynski JE. Investigating the use of contingency management of cocaine abuse among individuals with schizophrenia: a feasibility study. Psychiatry Res 2004, 125:61-64. 10.1016/j.psychres.2003.10.003, 14967553.
10. Shaner A, Roberts LJ, Eckman TA. Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatr Serv 1997, 48:807-810.
11. Sigmon SC, Steingard S, Badger GJ, Anthony SL, Higgins ST. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study. Exp Clin Psychopharmacol 2000, 8:509-517. 10.1037/1064-1297.8.4.509, 11127422.
12. Thyer BA, Irvine S, Santa CA. Contingency management of exercise by chronic schizophrenics. Percept Mot Skills 1984, 58:419-25.
13. Tidey JW, O'Neill SC, Higgins ST. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Exp Clin Psychopharmacol 2002, 10:241-247. 10.1037/1064-1297.10.3.241, 12233984.
14. Tracy K, Babuscio T, Nich C, Kiluk B, Carroll KM, Petry NM, Rounsaville BJ. Contingency management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders. Am J Drug Alcohol Abuse 2007, 33:253-258. 10.1080/00952990601174931, 17497548.
15. Olson PR, Greenberg DJ. Effects of contingency-contracting and decision-making groups with chronic mental patients. J Consult Clin Psychol 1972, 38(3):376-383. 10.1037/h0032910, 5032542.
16. Drebbing CE, Van Ormer A, Krebs C, Rosenheck R, Rounsaville B, Herz L, Penk W. The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans. J Appl Behav Anal 2005, 38:359-372. 10.1901/jaba.2005.100-03, 1226169, 16270845.
17. Claassen D, Fakhoury WK, Ford R, Priebe S. Money for medication: Financial incentives to improve medication adherence in assertive outreach. Psychiatr Bull R Coll Psychiatr 2007, 31:4-7.
18. Claassen D. Financial incentives for antipsychotic depot medication: ethical issues. J Med Ethics 2007, 33:189-193. 10.1136/jme.2006.016188, 17400613.
19. Beauchamp TL. Methods and principles in biomedical ethics. J Med Ethics 2003, 29:269-74. 10.1136/jme.29.5.269, 1733784, 14519835.
20. Remington G, Kwon J, Collins A, Laporte D, Mann S, Christensen B. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophr Res 2007, 90:229-237. 10.1016/j.schres.2006.11.015, 17208414.
21. Guy W. Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology, revised (DHEW Publ No ADM 76-338). 1976, 218-222. National Institute of Mental Health: Rockville, MD.
22. Priebe S, McCabe R, Bullenkamp J. Structured patient-clinician communication and one-year outcome in community mental health care: A cluster randomised controlled trial. Br J Psychiatry 2007, 191:420-426. 10.1192/bjp.bp.107.036939, 17978322.
23. Gharabawi GM, Greenspan A, Rupnow MFT, Kosik-Gonzalez C, Bossie CA, Zhu Y, Kalali AH, Awad AG. Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia. BMC Psychiatry 2006, 20(6):45.
24. Mangalore R, Knapp M, Jenkins R. Income-related inequality in mental health in Britain: the concentration index approach. Psychol Med 2007, 37:1037-1045. 10.1017/S003329170600969X, 17202002.
25. Eldridge S, Ashby D. Statistical Concepts (Master Classes in Primary Care Research) (No 3). 2000, London: Royal College of General Practitioners.
26. Eldridge S, Ashby D, Kerry S. Sample size for cluster randomised trials: effects of coefficient of variation of cluster size and analysis method. Int J Epidemiol 2006, 35:1292-1300. 10.1093/ije/dyl129, 16943232.